Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Gardner JM et al. - Long-term prognosis for advanced stages of cutaneous T-cell lymphoma may be beneficially altered with the use of multimodality therapy. However, refractory disease exists in which current therapeutic options fail to halt the progression of disease. The authors present 3 cases of refractory Sezary syndrome in which the combination of vorinostat and interferon gamma was well tolerated and produced significant clinical improvement.

Today in Basic Science/Genetics...keeping you current

Cutaneous zygomycosis due to Saksenaea vasiformis in an immunocompetent host
Indian Journal of Dermatology, 11/25/09

Tumor Mapping in 2 Large Multigenerational Families With CYLD Mutations
Archives of Dermatology, 11/25/09

Compounding dermatologic preparations in developing countries
Dermatologic Therapy, 11/24/09

Today in Dermatologic Oncology...keeping you current

Loco-regional control after postoperative radiotherapy for patients with regional nodal metastases from melanoma
Clinical and Translational Oncology, 11/25/09

Disappearance of Lentigines in a Patient Receiving Imatinib Treatment for Familial Gastrointestinal Stromal Tumor Syndrome
Archives of Dermatology, 11/25/09

Recurrent ovarian malignancy presenting as cutaneous metastasis
Indian Journal of Dermatology, 11/25/09

Today in Dermatopathology...keeping you current

Topical Calcipotriol for Preventive Treatment of Hypertrophic Scars
Archives of Dermatology, 11/25/09

Granulomatous Dermatitis With Pseudoxanthoma Elasticum-Like Changes
Archives of Dermatology, 11/25/09

Unexpected Occurrence of Xeroderma Pigmentosum in an Uncle and Nephew
Archives of Dermatology, 11/25/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address